Short answer
The risk associated with ayahuasca may be higher in the presence of cardiovascular, psychotic, manic or seizure disorders, during pregnancy and breastfeeding, and when interacting with medications or other substances. The strength of the evidence varies, so this list describes situations that call for greater caution and is not a substitute for individual medical evaluation. The final conclusion depends on the person’s current condition and full health history.
What “contraindication” means here
Contraindication is a condition or circumstance in which the expected risk may outweigh the possible benefit or becomes too uncertain. In the case of ayahuasca, there are no direct studies for many vulnerable groups. Therefore, conclusions are often based on known mechanism, toxicology, study exclusion criteria, and adverse event reports.
This creates an important limit: the lack of a controlled trial does not tell us how often complications occur, but also does not give grounds to consider the situation acceptable. Ethical protocols deliberately exclude people for whom the danger may be higher. Selection protects participants, but leaves less direct data about these groups in particular.
For a general overview of tolerability and serious events, see the safety of ayahuasca article. Here, the focus is not on the average frequency of reactions, but on situations where the individual level of risk may differ significantly.
Cardiovascular conditions
In controlled studies, ayahuasca may temporarily increase heart rate and blood pressure. For a healthy participant who has passed screening, such a change is not identical to a complication, but in the presence of unstable blood pressure, rhythm disturbances, significant heart disease or a recent acute event, the physiological reserve may be less.
Cardiovascular vulnerability is not defined by a single number. Current symptoms, exercise tolerance, history of loss of consciousness, concomitant conditions, and substances affecting pulse or blood pressure are important. That is why a short questionnaire with the answer "yes/no" cannot capture the full clinical picture.
Toxicological reviews emphasize the role of beta-carbolines, which transiently alter the activity of MAO-A. This mechanism is important not only for psychoactivity. It affects the metabolic environment and can change the reaction to other substances. The basic explanation can be found in the material about the mechanism of action of ayahuasca.
Psychosis, mania and psychiatric vulnerability
A systematic review of reports of psychotic episodes found few published cases, but some had antecedent psychotic or manic symptoms, family history, or concurrent substance use. Due to incomplete data, it is not possible to determine the exact individual risk, but the repeated signal deserves to be taken seriously.
History of psychosis or mania is important even when a person has not had acute symptoms for a long time. The intense change in perception, sleep, and emotional activation can interact with previous vulnerability. A family history does not mean an episode is inevitable, but it adds information that is not present in the study average.
Other mental states cannot automatically be reduced to the same level of risk. Anxiety, depressive symptoms, traumatic experiences, and personality disorders vary in course and severity. Relevant factors include current symptoms, stability, sleep, ability to remain oriented, and presence of crisis symptoms. A categorical list without these details would be misleading.
Seizures and other neurological risks
Seizures are mentioned among rare serious events in toxicology sources and case reports. The descriptions are not sufficient to calculate the exact risk for a specific neurological condition. At the same time, previous seizures, unexplained episodes of loss of consciousness, or acute neurological symptoms are reasons for professional evaluation, not for guessing from a general text.
Seizure vulnerability can depend on many factors: the underlying disease, sleep, temperature, other substances, and the stability of the condition. Determining the contribution of each element after an adverse event is difficult. That is why it is important not to turn the lack of direct research into a claim that there is no risk.
Impaired coordination and disorientation also pose an indirect risk of injury. Even without a seizure, a person may fall, fail to recognize a dangerous environment, or misjudge their own condition. These events are not always included in lists of pharmacological reactions, but are part of a real safety assessment.
Pregnancy and breastfeeding
Pregnancy and breast-feeding are barely represented in controlled studies of ayahuasca. There is no reliable body of data establishing safety for the fetus or infant. The physiological changes of pregnancy, acute changes in pressure, vomiting, dehydration, and exposure to active substances create several separate sources of uncertainty.
The argument "there is no evidence of harm" is incorrect here, because the absence of data is not evidence of the absence of an effect. The deliberate inclusion of pregnant women in such experiments has obvious ethical limitations. Therefore, caution arises not from the exact percentage, but from the high price of an unknown event and the impossibility of drawing a conclusion from healthy nonpregnant adults.
Medicines and other substances
Interaction with other substances is one of the most significant areas of risk. Beta-carbolines inhibit MAO-A, so the concomitant presence of substances affecting serotonin, pressure, temperature, or consciousness may alter the response. The exact profile depends on the specific substance, its pharmacology and the person's condition.
The general name of a group of drugs does not give a ready answer. Drugs within the same category may have different half-lives, active metabolites, and additional targets. Changing treatment on your own can also make your condition worse. An informational article cannot provide a schedule or instructions for changing prescribed medication.
The unknown composition of the botanical material itself adds further uncertainty. The article on the composition of ayahuasca explains why different samples are not interchangeable. If it is not known which components and concentrations are present, the interaction prediction becomes even less reliable.
Why the questionnaire does not replace a medical assessment
The questionnaire is useful for the initial collection of information, but its quality depends on the questions, the understanding of the terms and the completeness of the answers. A person may not know the name of the diagnosis, may not consider fainting to be an important symptom, or may not remember a medication they take occasionally. An unchecked box does not establish that a risk factor is absent.
- current symptoms and their stability;
- previous episodes of psychosis, mania, seizures, or fainting;
- all medications taken regularly or occasionally and other substances;
- cardiovascular and neurological conditions;
- pregnancy, breastfeeding and other physiological circumstances.
A realistic assessment needs to link symptoms, history, and possible interactions. If data are lacking, the honest conclusion may be that the level of risk cannot be determined with sufficient confidence.
How to read lists of contraindications
A list that is too short creates the false impression that everything not mentioned is automatically acceptable. An excessively long, unsourced list mixes proven interactions, theoretical speculation, and general caution. Well-written content shows what each point is based on and how direct the data is.
The strongest signal is a combination of a known mechanism, repeated reports, and consistent exclusion of a group from studies. Weaker is a single report with an unknown composition and many alternative explanations. Weak evidence does not equal zero risk; it means that numerical precision must be limited.
It is also important to distinguish between an established diagnosis and a person's current condition. The name of the disease without information about the course does not describe the whole situation, and an acute symptom can be significant even without an established diagnosis. This is another reason why the article cannot replace an individual assessment.
What can be learned from the exclusion criteria
The study protocol determines in advance who will not be included. This list shows which situations the team considered sufficiently uncertain or risky not to test experimentally. The criteria are useful for understanding the limits of the sample, but do not by themselves measure the incidence of complications in the excluded group.
If people with a certain condition were not among the participants, the favorable result of the study does not automatically apply to them. At the same time, the exclusion may be wider than the proven risk: researchers often choose a margin of caution because of the small expected benefit of the experiment and the high cost of the possible event.
When comparing publications, it is worth looking not only at the results, but also at who was excluded from the studies. Two studies with the same incidence of adverse events may have different safety profiles if one excluded significantly more conditions. A clear account explains this difference and does not mistake the selected sample for the general population. This is essential for an honest conclusion.
What is confirmed, and where the data is lacking
It is well established that ayahuasca can acutely alter heart rate, blood pressure, perception, and consciousness, and beta-carbolines affect MAO-A. Reviews of reports of psychosis show a recurring focus on prior vulnerability and other substances. General toxicological principles support caution for significant cardiovascular and neurological conditions.
Data are lacking for exact frequencies in each clinical group, pregnancy, breast-feeding and many drug combinations. People at higher expected risk are often excluded from trials. Therefore, a scientifically correct conclusion names the direction of the risk, but does not invent the exact percentage.
The described acute effects of ayahuasca help to understand why the same reaction can have different meanings for a healthy participant who has passed screening and for a person with greater physical or psychological vulnerability. The level of risk is assessed from the available clinical information, not the popularity of the practice.